A recent study, published in The American Journal of Psychiatry, has shed light on the mechanisms behind the brain’s response to stress in those with post-traumatic stress disorder (PTSD) and major depressive disorder (MDD). The implications of this study are far-reaching, from improving our understanding of the cellular and molecular basis of PTSD and MDD to potentially revolutionizing the diagnosis and treatment of these challenging neuropsychiatric disorders. The findings open up exciting avenues for further research, personalized medicine, and the development of targeted therapeutic interventions.
In a new proof of concept study, researchers have identified a biomarker in human platelets that can track depression and […]
Researchers have undertaken a brain proteome-wide association study (PWAS), identifying novel proteins that may be targets for new depression treatments. […]
Researchers have reported that male mice showing depression-like behaviours were able to pass those traits onto their offspring, specifically through […]
A recent paper, published in Translational Psychiatry, uses monocyte gene expression to gain insight into childhood trauma, suicide risk and […]
Welcome back to Week in Brief, your number one stop for all the latest omics news. We’ll start with this […]
Looking for a summary of the latest news in the genomics space? You’re in the right place! Welcome back to […]
With the ever-increasing potential of new technology and the exponential growth of the life sciences field, researchers are always running […]
Welcome to the latest Week in Brief, where we provide a summary of cutting-edge research from the last seven days! […]
Original post written by Lyndsey Fletcher in January 2023. Updated in August 2023 by Aleisha Collins. How can we sum […]
